International Assets Investment Management LLC reduced its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) by 85.2% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 16,663 shares of the pharmacy operator’s stock after selling 96,280 shares during the period. International Assets Investment Management LLC’s holdings in Walgreens Boots Alliance were worth $186,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Asset Management One Co. Ltd. grew its position in shares of Walgreens Boots Alliance by 1.9% during the 1st quarter. Asset Management One Co. Ltd. now owns 302,358 shares of the pharmacy operator’s stock worth $3,377,000 after buying an additional 5,648 shares during the period. Scharf Investments LLC bought a new position in Walgreens Boots Alliance in the first quarter valued at approximately $8,310,000. Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in Walgreens Boots Alliance during the 1st quarter worth $233,000. Arrow Investment Advisors LLC bought a new stake in shares of Walgreens Boots Alliance during the 1st quarter valued at $318,000. Finally, State of Alaska Department of Revenue raised its position in shares of Walgreens Boots Alliance by 2.6% during the 1st quarter. State of Alaska Department of Revenue now owns 84,053 shares of the pharmacy operator’s stock valued at $938,000 after acquiring an additional 2,145 shares during the last quarter. Institutional investors own 58.59% of the company’s stock.
Analysts Set New Price Targets
A number of equities research analysts recently commented on WBA shares. Morgan Stanley reaffirmed an “underweight” rating on shares of Walgreens Boots Alliance in a research note on Thursday. Wall Street Zen began coverage on Walgreens Boots Alliance in a research report on Wednesday, May 21st. They set a “hold” rating for the company. Finally, UBS Group reiterated a “neutral” rating on shares of Walgreens Boots Alliance in a research report on Thursday. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $10.59.
Insider Buying and Selling
In other Walgreens Boots Alliance news, Chairman Stefano Pessina purchased 832,258 shares of the firm’s stock in a transaction dated Sunday, April 27th. The stock was bought at an average cost of $11.01 per share, with a total value of $9,163,160.58. Following the purchase, the chairman now directly owns 145,621,079 shares of the company’s stock, valued at $1,603,288,079.79. The trade was a 0.57% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 17.50% of the company’s stock.
Walgreens Boots Alliance Price Performance
NASDAQ WBA opened at $11.45 on Friday. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.32 and a current ratio of 0.61. The stock has a market cap of $9.91 billion, a price-to-earnings ratio of -1.57, a PEG ratio of 1.36 and a beta of 0.78. The business has a 50 day simple moving average of $11.21 and a 200 day simple moving average of $10.83. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $13.25.
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last issued its quarterly earnings data on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.04. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 16.39%. The company had revenue of $38.99 billion during the quarter, compared to the consensus estimate of $36.72 billion. During the same quarter in the prior year, the firm earned $0.63 earnings per share. The firm’s revenue was up 7.2% compared to the same quarter last year. Analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
See Also
- Five stocks we like better than Walgreens Boots Alliance
- How to Plot Fibonacci Price Inflection Levels
- Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Value Alert: 3 High-Yield Stocks Trading at 52-Week Lows
- ETF Screener: Uses and Step-by-Step Guide
- Nektar Jumps 157% on Drug Trial Data—Can It Go Even Higher?
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.